Kyle D. Perry

发表

Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.

W. Chan, T. Greiner, D. Weisenburger, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.